The short answer
A combined blood-pressure effect from niacin and abaloparatide is plausible, but direct clinical evidence for the pair was not found in the targeted search. Abaloparatide can cause dizziness or a blood-pressure drop after injection. High-dose nicotinic acid has its own hypotension warnings; these should not be applied automatically to every vitamin-B3 product or nutritional dose.
What this answer covers
Abaloparatide 80 mcg/day by subcutaneous injection in osteoporosis care; not teriparatide or another parathyroid-hormone product.
- Supplement or preparation
- niacin
- Medication ingredient
- abaloparatide
Why might there be a concern?
TYMLOS can cause orthostatic symptoms, often within four hours of an injection. Prescription nicotinic acid labeling includes hypotension and cautions with vasoactive drugs. These separate observations suggest a possible additive effect, but neither label supplies a measured risk for taking these two products together.
Which niacin product matters?
The inspected source concerns extended-release nicotinic acid used at lipid-altering doses. It does not establish the same blood-pressure effect for an ordinary multivitamin dose, nicotinamide or every product sold as vitamin B3. Bring the exact label and amount to the discussion.
What can I do with this information?
Tell your pharmacist or prescriber about the niacin product and any dizziness or faintness. TYMLOS instructions say to sit or lie down when post-injection symptoms occur and to seek prescriber advice if they persist or worsen. Do not invent a spacing schedule: no interval was established for this combination.
How certain is the interaction?
A direct trial or case report establishing hypotension from niacin plus abaloparatide was not identified in the targeted search. The possibility follows from their separate effects. The evidence is insufficient to confirm the interaction or declare the combination safe.
Evidence and practical considerations
Side effects & toxicity
A combined blood-pressure effect from niacin and abaloparatide is plausible, but direct clinical evidence for the pair was not found in the targeted search. Abaloparatide can cause dizziness or a blood-pressure drop after injection. High-dose nicotinic acid has its own hypotension warnings; these should not be applied automatically to every vitamin-B3 product or nutritional dose.
- Exact scope
- Niacin as an oral product, retaining the exact formulation and dose limitations in the article. with Abaloparatide 80 mcg/day by subcutaneous injection in osteoporosis care; not teriparatide or another parathyroid-hormone product.
- Medication form and route
- subcutaneous abaloparatide injection
- Timing or duration
- Post-injection orthostatic symptoms may occur within four hours; this is not a tested niacin spacing interval.
What remains uncertain
- Evidence is indirect from separate product labels. The precise supplement form and dose are unspecified in the original statement; no retrieved exact-pair trial, case series, incidence estimate or effective separation interval.
Factors that may matter: nicotinic-acid dose and formulation; existing dizziness or orthostatic symptoms; other vasoactive medicines.
Read the supporting source summaries
Source 1: regulatory product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Postmenopausal women and men with osteoporosis at high fracture risk.
Recommends calcium and vitamin D if intake is inadequate; warns about hypercalcemia, hypercalciuria and post-injection orthostatic hypotension.
How this applies: Separate-product hypotension evidence only; no direct niacin/abaloparatide estimate.
No specific drug-drug interaction studies were performed. The label does not isolate the extra risk from a particular supplement dose.
Source 2: regulatory product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed lipid-altering doses of nicotinic acid.
Postmarketing reports include hypotension and syncope; warns about increased effects of vasoactive agents.
How this applies: Separate-product hypotension evidence only; no direct niacin/abaloparatide estimate.
Does not name or test abaloparatide. Prescription nicotinic acid is not equivalent to every vitamin-B3 formulation or nutritional dose.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original sources checked; exact preparation and timing limits assessed; consumer article drafted and existing checker statements reconciled. | |
| Consumer explanations clarified without changing the evidence assessment. | |
| Research summary published |
Article revision: 7e44ee3701a62aaa
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.